Paclitaxel Plus Radiation Therapy in Treating Patients With Untreated Stage III Non-small Cell Lung Cancer
Status:
Completed
Trial end date:
2000-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining radiation therapy with chemotherapy may kill more tumor
cells.
PURPOSE: Phase I trial to study the effectiveness of chemotherapy with paclitaxel in
combination with radiation therapy to the chest in patients with previously untreated stage
III non-small cell lung cancer that cannot be surgically removed.